Medical reviewer
Cushing Professor of Medicine at Yale School of Medicine. Founding director of the Yale Obesity Research Center. Lead investigator on the pivotal retatrutide, tirzepatide and maridebart cafraglutide trials.
Education and training
| Stage | Institution | Year |
|---|---|---|
| BA, Art History (music minor), magna cum laude | Bucknell University | 1998 |
| MD | University of Maryland at Baltimore | 2002 |
| Residency, Internal Medicine / Pediatrics | University of Maryland School of Medicine | 2006 |
| Dual fellowship, Adult and Pediatric Endocrinology | Yale School of Medicine | 2011 |
| PhD, Investigative Medicine | Yale Graduate School | 2012 |
Board certifications
Board certified in five specialties: internal medicine, pediatrics, endocrinology/diabetes/metabolism, pediatric endocrinology, and obesity medicine.
Current positions
- Harvey and Kate Cushing Professor of Medicine (Endocrinology), Yale School of Medicine
- Professor of Pediatrics (Endocrinology)
- Founding Director, Yale Obesity Research Center (Y-Weight)
- Co-Director, Yale Center for Weight Management
Research areas
Obesity pharmacotherapy; nutrient-stimulated hormone (NuSH)-based therapies; the neurobiology underlying obesity studied with fMRI and PET neuroimaging; mechanisms of action of anti-obesity medications; large multicentre clinical outcomes trials.
112 publications, 12,422 citations.
Lead investigator on landmark trials
All published in the New England Journal of Medicine:
- Tirzepatide (dual GIP/GLP-1 receptor agonist), SURMOUNT programme, NEJM 2022 and 2024
- Retatrutide (triple GIP/GLP-1/glucagon receptor agonist), NEJM 2023
- Maridebart cafraglutide / MariTide (GIP receptor antagonist / GLP-1 receptor agonist), NEJM 2025
Book
Enough: Your Health, Your Weight, and What It's Like To Be Free co-authored with Oprah Winfrey. Simon & Schuster, January 2026. #1 National Bestseller.
Awards
The Obesity Society Clinician of the Year (2023), NIH/NIDDK K23 Mentored Patient-Oriented Research Career Development Award (2014), New York Times Best-Selling Author (2026).
Retatrutide-Peptide.biz